This thread is for Nevro news. We will continually update the thread with the most recent and relevant news and social media posts for the company.
If you like, feel free to share your opinions or add an article or tweet to this thread.
Medtech[y]
Posted 2 years ago
This thread is for Nevro news. We will continually update the thread with the most recent and relevant news and social media posts for the company.
If you like, feel free to share your opinions or add an article or tweet to this thread.
Medtech[y]
Posted 3 months ago
Nevro Revenue Growth Slows in the Third Quarter $NVRO | Medtechy https://t.co/uUoUIgyGzC
— medtech[y] (@medtechy) November 6, 2018
Interesting report. As it turns out, churning through sales people is really expensive. I guess they don't teach that in the Wharton MBA program.
Posted 3 months ago
Nevro Revenue Growth Slows in the Third Quarter $NVRO | Medtechy https://t.co/uUoUIgyGzC
— medtech[y] (@medtechy) November 6, 2018
Posted 7 months ago
Nevro and Boston Scientific Agree to Terminate Patent Dispute $NVRO $BSX | Medtechy pic.twitter.com/PzYrOc1YRd
— medtech[y] (@medtechy) July 30, 2018
Posted 7 months ago
Nevro tops Q2 preliminary revenue and updates FY guidance after parting ways with VP of sales $NVRO| Medtechy pic.twitter.com/mVbk8Nx9Q4
— medtech[y] (@medtechy) July 16, 2018
Posted 7 months ago
Nevro fires sales VP. Stock down over 17% $NVRO | Medtechy pic.twitter.com/emvldkPyR0
— medtech[y] (@medtechy) July 13, 2018
Posted 2 years ago
Posted 2 years ago
REDWOOD CITY, Calif., July 5, 2017 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is...
Posted 2 years ago
Neurosurgery Selects the SENZA RCT 24 Month Outcomes Publication as the Top Pain Paper of the Year by medtechy on Scribd
Why werent explants one of the end points of the study? It would have been more real world.
Posted 2 years ago
Posted 2 years ago
Nevro misses by $0.25, misses on revenue https://t.co/7fQTuvPN61 $NVRO
— Seeking Alpha (@SEEKINGALPHA_FS) May 8, 2017
nice qtr. coming up...NO
Posted 2 years ago
Nevro misses by $0.25, misses on revenue $NVRO
— Seeking Alpha (@SEEKINGALPHA_FS) May 8, 2017
Posted 2 years ago
The HF10 works like a pacemaker
Posted 2 years ago
Nevro: Increased Access To HF10 Therapy Will Power Stock Price $NVRO
— Seeking Alpha (@SeekingAlpha) March 29, 2017
Posted 2 years ago
$NVRO Mgmt@ $JPM -plans to exit '17 w full coverage of US market, but don't want to commit to a specific # of reps=street'17 reps # too low https://t.co/oZjjjrOTOe
— YourPersonalTrader (@Yourpersonaltr1) March 28, 2017
Posted 2 years ago
$NVRO back to triple-digits today .. SCS in the house
— Option Millionaires (@OMillionaires) February 27, 2017